BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36232418)

  • 1. Somatic Mutational Landscape in Mexican Patients:
    Cerrato-Izaguirre D; Chirino YI; Prada D; Quezada-Maldonado EM; Herrera LA; Hernández-Guerrero A; Alonso-Larraga JO; Herrera-Goepfert R; Oñate-Ocaña LF; Cantú-de-León D; Meneses-García A; Basurto-Lozada P; Robles-Espinoza CD; Camacho J; García-Cuellar CM; Sánchez-Pérez Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline
    Wang SC; Yeu Y; Hammer STG; Xiao S; Zhu M; Hong C; Clemenceau JR; Yoon LY; Nassour I; Shen J; Agarwal D; Reznik SI; Mansour JC; Yopp AC; Zhu H; Hwang TH; Porembka MR
    Cancer Res; 2020 Jun; 80(11):2114-2124. PubMed ID: 32269045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
    Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
    Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
    Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
    J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE STUDY OF THE EXPRESSION OF CDH1, KI67, P53 AND HER2 IN DIFFUSE GASTRIC CARCINOMA.
    Muzashvili T; Tutisani A; Chabradze G; Beridze N; Museridze N
    Georgian Med News; 2020 Feb; (299):147-150. PubMed ID: 32242863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
    São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
    Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.
    Cerrato-Izaguirre D; Chirino YI; García-Cuellar CM; Santibáñez-Andrade M; Prada D; Hernández-Guerrero A; Larraga OA; Camacho J; Sánchez-Pérez Y
    Genes Dis; 2022 Jul; 9(4):928-940. PubMed ID: 35685475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
    Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
    World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
    Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
    World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of E-Cadherin and
    García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
    Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma.
    Zhang M; Sugita I; Komura D; Katoh H; Shimada S; Inazawa J; Tanaka S; Ishikawa S
    Gastric Cancer; 2022 Jan; 25(1):83-95. PubMed ID: 34387762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
    Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
    Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.